UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,736,393
+154.8%
42,971
+176.6%
0.00%
Q1 2024$1,074,004
+25.4%
15,5360.0%0.00%
Q4 2023$856,655
-5.0%
15,5360.0%0.00%
Q3 2023$902,020
+123.7%
15,536
+53.0%
0.00%
Q2 2023$403,2780.0%10,1530.0%0.00%
Q1 2023$403,278
+96.9%
10,153
+99.4%
0.00%
Q4 2022$204,851
-99.9%
5,092
-21.5%
0.00%
Q3 2022$208,428,000
-13.5%
6,485
-20.2%
0.00%
Q2 2022$241,009,000
+12.7%
8,123
+6.8%
0.00%
Q1 2022$213,889,000
-39.0%
7,6090.0%0.00%
Q4 2021$350,623,000
+40.4%
7,6090.0%0.00%
Q3 2021$249,729,000
-6.4%
7,6090.0%0.00%
Q2 2021$266,696,000
+8.8%
7,609
+12.2%
0.00%
Q1 2021$245,101,000
+4.7%
6,782
+18.0%
0.00%
Q1 2020$234,092,000
-36.9%
5,746
-4.4%
0.00%
Q4 2019$370,821,000
-27.3%
6,013
-14.1%
0.00%
Q3 2019$510,015,000
+13.9%
6,998
+28.5%
0.00%
Q2 2019$447,661,000
+32.5%
5,446
+13.7%
0.00%
Q1 2019$337,887,000
+791.4%
4,790
+468.9%
0.00%
Q4 2018$37,907,000
+12049.7%
842
-82.1%
0.00%
Q3 2016$312,000
+26.8%
4,700
+6.8%
0.00%
Q2 2016$246,000
+13.4%
4,400
-8.3%
0.00%
Q4 2015$217,000
-20.5%
4,800
+9.1%
0.00%
Q2 2015$273,0004,4000.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders